Literature DB >> 2430924

The mechanism of activation of human natural killer cells by medullasin.

Y Aoki.   

Abstract

Medullasin, a serine protease in granulocytes, has been shown to stimulate human natural killer cell activity through its proteolytic activity, without interferon induction. The protease is considered to exert its effect directly on large granular lymphocytes, because firstly the extent of activation of natural killer cell activity by medullasin was the same between peripheral blood lymphocytes and purified large granular lymphocytes, and secondly, addition of medullasin-treated lymphocyte fractions containing few large granular lymphocytes to the large granular lymphocyte fraction failed to enhance the natural killer cell activity of that fraction. Studies employing inhibitors of DNA, RNA and protein synthesis showed that both RNA and protein synthesis, but not DNA synthesis of lymphocytes are necessary for the enhancement of natural killer cell activity by medullasin. These results indicate that medullasin in granulocytes enhances the natural killer cell activity by directly stimulating large granular lymphocytes to induce certain protein(s).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430924

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  4 in total

1.  Shiga toxin 2 induces macrophage-granulocyte colonies from human bone marrow and cord blood stem cells.

Authors:  Shin Chiyoda; Tae Takeda; Yosuke Aoki
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Induction of activated killer cells from human lymphocytes by medullasin (a serine protease in bone marrow cells).

Authors:  Y Aoki; T Hase; K Oshimi; K Suzuki
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Cathepsin G enhances human natural killer cytotoxicity.

Authors:  T Yamazaki; Y Aoki
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

4.  Medullasin induces activated killer cells from human lymphocytes.

Authors:  Y Aoki
Journal:  Jpn J Cancer Res       Date:  1988-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.